immune system
• migration of neutrophils to the neutrophil-attracting chemokine CXCL1 is reduced by 50% when compared with wild-type neutrophils
|
• abnormal dendritic cell migartion as measured by the decreased accumulation of peripheral antigen in the draining lymph node, non-draining lymph node, bone marrow or spleen
• hapten application to skin does not result in dendritic cell egress as it does in wild-type mice
• reduced migration toward CCR7 and CXCR4 ligands CCL19, CCL21A, and CXCL12 in an in vitro transwell assay
|
• the accumulation of myeloperoxidase-positive neutrophils in the skin is significantly reduced in hapten-treated ears compared with wild-type mice
|
• after mice are sensitized topically on the abdomen with either oxazolone or FITC and elicited 5 d later on the ear there is significantly reduced swelling and reduced cellular accumulation at the site of elicitation
|
hematopoietic system
• migration of neutrophils to the neutrophil-attracting chemokine CXCL1 is reduced by 50% when compared with wild-type neutrophils
|
• abnormal dendritic cell migartion as measured by the decreased accumulation of peripheral antigen in the draining lymph node, non-draining lymph node, bone marrow or spleen
• hapten application to skin does not result in dendritic cell egress as it does in wild-type mice
• reduced migration toward CCR7 and CXCR4 ligands CCL19, CCL21A, and CXCL12 in an in vitro transwell assay
|
• the accumulation of myeloperoxidase-positive neutrophils in the skin is significantly reduced in hapten-treated ears compared with wild-type mice
|
cellular
• migration of neutrophils to the neutrophil-attracting chemokine CXCL1 is reduced by 50% when compared with wild-type neutrophils
|
• abnormal dendritic cell migartion as measured by the decreased accumulation of peripheral antigen in the draining lymph node, non-draining lymph node, bone marrow or spleen
• hapten application to skin does not result in dendritic cell egress as it does in wild-type mice
• reduced migration toward CCR7 and CXCR4 ligands CCL19, CCL21A, and CXCL12 in an in vitro transwell assay
|